everi
child
world
infect
gastroenter
virus
first
year
life
develop
world
result
substanti
morbid
glass
et
al
expens
develop
countri
hundr
thousand
children
die
medicin
good
deal
differ
outcom
due
differ
avail
treatment
viral
gastroenter
mainli
rotaviru
infect
directli
caus
death
dehydr
thu
treatment
prevent
dehydr
first
goal
care
infant
gastroenter
viral
gastroenter
also
inflict
consider
nutrit
insult
children
due
anorexia
vomit
malabsorpt
tradit
therapi
nutrit
poor
diet
offer
jelliff
final
bout
viral
gastroenter
serv
trigger
point
extend
downward
spiral
chronic
diarrhea
malnutrit
haffeje
optim
solut
diseas
burden
viral
gastroenter
would
prevent
via
effect
vaccin
option
remain
sever
year
away
section
discuss
treatment
defici
fluid
electrolyt
nutrient
alreadi
good
costeffect
strategi
correct
sequela
viral
gastroenter
littl
yet
avail
effect
treat
acut
symptom
vomit
diarrhea
sever
potenti
mode
symptomat
therapi
viral
gastroenter
discuss
includ
probiot
antivir
passiv
immunotherapi
antidiarrh
tradit
therapi
diarrheal
diseas
often
base
empir
observ
withhold
feed
fluid
result
less
stool
jelliff
obvious
may
lead
disastr
consequ
sever
gastroenter
dehydr
first
major
advanc
treatment
dehydr
develop
effect
intraven
rehydr
therapi
intraven
therapi
requir
sophist
rel
expens
equip
expertis
thu
effect
rehydr
therapi
remain
unavail
world
children
initi
attempt
produc
solut
oral
rehydr
therapi
ort
contain
excess
glucos
led
frequent
osmot
diarrhea
hypernatrem
dehydr
paneth
legaci
earli
solut
live
concern
hypernatremia
ort
even
improv
formul
develop
effect
ort
late
offshoot
increas
knowledg
intestin
absorpt
physiolog
essenti
idea
glucos
coupl
sodium
transport
fundament
mechan
sodium
water
absorpt
hirschhorn
advanc
rehydr
includ
realiz
rapid
rehydr
prompt
refeed
improv
outcom
although
much
debat
specul
continu
rel
contribut
variou
pathophysiolog
mechan
viral
gastroenter
net
result
moder
sever
diseas
deficit
bodi
water
sodium
known
dehydr
rel
deficit
sodium
water
determin
whether
child
hypo
normo
hypernatrem
dehydr
first
step
treatment
assess
degre
dehydr
tabl
list
sign
symptom
use
assess
mild
moder
sever
dehydr
unlik
adult
children
tend
maintain
blood
pressur
advanc
state
hypovolemia
reach
child
nearli
shock
otherwis
obtund
rehydr
commenc
rapid
intraven
administr
mlkg
isoton
fluid
normal
salin
lactat
ringer
solut
meql
na
meql
k
meql
ci
meql
great
major
infant
shock
may
commenc
ort
variou
ort
formul
studi
use
tabl
modern
ort
solut
gener
contain
meq
sodium
per
liter
approxim
equimolar
carbohydr
glucos
glucos
polym
world
health
organ
recommend
ort
glucos
sodium
molar
ratio
greater
glucos
polym
advantag
lower
solut
osmolar
although
metaanalysi
treatment
non
cholera
mostli
rotaviru
diarrhea
suggest
slight
advantag
ricebas
polym
solut
gore
et
al
ort
solut
util
tradit
complex
carbohydr
sourc
found
rice
water
produc
low
osmolar
solut
may
cultur
accept
solut
contain
approxim
meq
potassium
make
enter
loss
form
acet
bicarbon
citrat
least
one
author
suggest
base
content
critic
success
rehydr
walkersmith
solut
design
ort
sport
drink
soft
drink
broth
inappropri
danger
due
either
excess
carbohydr
salt
composit
appropri
inappropri
solut
shown
tabl
addit
substanc
amino
acid
ad
ort
attempt
capit
intestin
cotransport
system
proven
clinic
superior
glucos
base
ort
bhan
ort
administ
bottl
cup
spoon
nasogastr
tube
vomit
minim
administ
ort
slowli
goal
achiev
rehydr
within
first
four
hour
therapi
fluid
deficit
calcul
bodi
weight
one
percent
estim
dehydr
bodi
weight
loss
tabl
one
simpl
practic
recommend
administ
one
teaspoon
ml
ort
minut
typic
kg
infant
would
provid
first
hour
therapi
properli
administ
ort
shown
repeatedli
effect
hypoand
hypernatrem
dehydr
lower
incid
seizur
observ
intraven
therapi
pizarro
pizarro
rehydr
achiev
regular
feed
resum
ort
offer
stool
compens
ongo
fluid
salt
loss
diarrhea
episod
resolv
develop
develop
world
slow
refeed
establish
tradit
practic
deriv
observ
stool
increas
immedi
feed
recent
number
studi
develop
develop
countri
shown
durat
nutrit
impact
acut
gastroenter
reduc
offer
reason
age
appropri
diet
soon
rehydr
complet
hjelt
et
al
quak
et
al
breastf
infant
nurs
throughout
rehydr
period
surpris
older
clinician
number
studi
shown
infant
gastroenter
toler
lactosecontain
diet
quit
well
although
occasion
infant
may
develop
sever
osmot
diarrhea
due
acquir
lactas
defici
armitstead
et
al
haffeje
szajewska
et
al
consider
interest
whether
specif
nutrit
intervent
could
acceler
recoveri
diarrheal
ill
recent
studi
bangladesh
shown
cook
green
banana
pectin
ad
normal
diet
hasten
resolut
chronic
diarrhea
rabbani
micronutri
also
examin
possibl
therapi
acut
diarrhea
vitamin
given
prophylact
area
world
children
risk
defici
seem
decreas
childhood
mortalitymorbid
diarrhea
respiratori
ill
rahman
result
vitamin
therapi
acut
diarrhea
less
impress
dewan
yurdakok
khatun
zinc
supplement
shown
hasten
resolut
acut
wateri
diarrhea
develop
world
bhutta
whether
supplement
would
effect
develop
nation
defici
much
less
common
known
probiot
live
cultur
nonpathogen
bacteria
administ
therapi
prophylaxi
rule
strain
stabli
colon
gut
thu
continu
dose
requir
strain
easili
recov
stool
varieti
strain
bacteria
yeast
use
treat
prevent
diarrhea
mani
strain
lactobacilli
found
yogurt
other
bifidobacteria
deriv
flora
breast
fed
infant
saccharomyc
bouladi
nonpathogen
yeast
excel
safeti
profil
observ
mechan
probiot
protect
gut
remain
unclear
hypothes
includ
chang
lumin
ph
due
local
ferment
competit
pathogen
mucos
receptor
stimul
local
immun
system
activ
enterocyt
secret
specif
cytokin
marteau
evid
probiot
therapi
enhanc
iga
respons
rotaviru
majamaa
et
al
lactobacillu
gg
shown
reduc
durat
rotaviru
excret
probiot
studi
extens
rotaviru
gastroenter
lactobacillu
spp
wide
use
one
larg
subject
doubleblind
european
multicent
studi
lactobacillu
gg
placebo
administ
ort
children
acut
diarrhea
guandalini
et
al
patient
rel
mild
symptom
rotavirusinfect
children
treat
experienc
hour
less
diarrhea
receiv
placebo
ten
percent
placebotr
infant
symptom
longer
one
week
compar
percent
lactobacillustr
infant
recent
metaanalysi
lactobacillu
therapi
childhood
diarrhea
conclud
effect
treatment
clinic
signific
reduc
durat
stool
less
one
day
remain
question
van
niel
et
al
perhap
new
well
power
trial
earli
intervent
might
examin
relev
endpoint
determin
whether
probiot
therapi
prevent
hospit
need
intraven
rehydr
studi
probiot
acut
infantil
diarrhea
taken
place
develop
countri
need
extend
studi
develop
world
need
acut
baselin
intestin
microflora
quit
differ
antivir
drug
therapi
viral
gastroenter
explor
mainli
laboratori
number
compound
shown
inhibitori
rotaviru
replic
vitro
includ
ribavirin
isoflavin
adenosin
analogu
smee
de
et
al
kitaoka
et
al
probabl
owe
antirotaviru
activ
inhibit
sadenosylhomocystein
hydrolas
key
enzym
regul
methyl
includ
requir
matur
viral
mrna
result
use
drug
anim
experi
larg
unimpress
schoub
smee
kitaoka
et
al
number
herbal
tea
extract
also
report
inhibit
rotaviru
vitro
husson
et
al
clark
et
al
kudi
myint
essenti
question
antivir
therapi
gastroenter
whether
much
clinic
benefit
expect
rotaviru
alreadi
done
damag
prior
onset
symptom
diseas
natur
durat
day
sever
approach
inhibit
rotaviru
infect
examin
proteas
inhibitor
administ
enter
prevent
trypsinmedi
cleavag
essenti
rotaviru
replic
increas
infect
vonderfecht
et
al
unfortun
sever
inhibit
gut
lumin
proteas
lead
sever
protein
maldigest
thu
practic
therapi
anoth
approach
administr
glycoprotein
lipid
may
function
pseudoreceptor
receptor
competitor
viru
entiti
identifi
human
breast
milk
intestin
mucin
yolken
et
al
yolken
et
al
kiefel
et
al
read
et
al
none
approach
report
clinic
trial
passiv
immunotherapi
examin
prevent
treatment
viral
gastroenter
antibodi
human
bovin
egg
yolk
deriv
administ
enter
infant
rotaviru
diarrhea
mani
studi
shown
decreas
stool
treat
infant
human
serum
immunoglobulin
contain
rotavirusspecif
antibodi
administ
oral
immunocompromis
children
chronic
rotaviru
infect
abl
associ
rotaviru
gut
result
format
larg
immun
complex
rather
free
viru
antigen
shed
significantli
reduc
antibodi
therapi
although
viru
elimin
case
losonski
et
al
enter
administr
antibodi
shown
efficaci
normal
children
singl
dose
human
immunoglobulin
prepar
high
neutral
titer
rotaviru
significantli
acceler
rate
viru
clearanc
recoveri
diarrhea
children
infect
rotaviru
guarino
et
al
howev
anoth
similar
studi
show
signific
effect
oral
administ
immunoglobulin
ventura
et
al
bovin
immunoglobulin
rotaviru
produc
hyperimmun
cattl
human
rotavirus
brtissow
et
al
either
milk
hyperimmun
cattl
serum
immunoglobulin
resuspend
milk
formula
significantli
reduc
incid
rotaviru
ill
month
old
children
oral
administ
result
treatment
activ
diseas
bovin
antibodi
also
produc
conflict
result
studi
effect
observ
other
diarrhea
reduc
sarker
et
al
altern
mean
produc
antirotaviru
immunoglobulin
harvest
specif
immunoglobulin
yolk
egg
laid
chicken
immun
rotaviru
egg
yolk
contain
larg
quantiti
specif
immunoglobulin
follow
intramuscular
immun
hen
antibodi
remain
stabl
long
period
time
oral
dose
mice
calv
immunoglobulin
significantli
reduc
overal
diseas
ebina
et
al
kuroki
et
al
kuroki
et
al
mice
protect
directli
associ
reduc
rotaviru
antigen
distribut
within
intestin
tract
suggest
replic
viru
inhibit
recent
human
trial
bangladesh
suggest
egg
yolk
prepar
may
potenti
therapeut
valu
human
infant
well
sarker
cytokin
hormon
play
import
role
host
defens
self
regul
examin
potenti
therapeut
agent
viral
gastroenter
interferon
cytokin
discov
name
antivir
properti
rotaviru
astroviru
sensit
vivo
effect
class
class
ii
interferon
well
interleukin
bass
howev
mice
treatment
ifn
effect
rotaviru
replic
diseas
angel
et
al
knockout
mice
lack
receptor
class
ifn
ifn
gamma
neg
mice
clear
viru
easili
normal
counterpart
result
hint
mucos
host
defens
system
multipl
level
redund
calv
ifn
report
efficaci
suppress
rotaviru
diseas
schwer
et
al
cytokin
hormon
affect
intestin
epitheli
integr
epitheli
growth
factor
tgf
hydrocortison
thyroid
hormon
test
experiment
therapeut
aid
viral
enter
despit
improv
function
assay
infect
epithelium
epiderm
growth
factor
tgf
fail
decreas
diarrhea
increas
weight
gain
infect
swine
zijlstra
rhoad
et
al
corticosteroid
lead
earli
matur
suckl
mous
gut
prevent
symptomat
murin
rotaviru
edim
infect
wolf
et
al
corticosteroid
treatment
suckl
pig
infect
transmiss
gastroenter
viru
lead
improv
villou
structur
improv
sodium
transport
intestin
mucosa
rhoad
et
al
vivo
experi
suggest
prostaglandin
may
exert
antivir
effect
rotavirus
superti
et
al
therapi
aim
symptom
viral
gastroenter
use
young
children
typic
sever
diseas
compound
kaolin
smectit
pysillium
fiber
chang
consist
stool
bind
free
water
realli
alter
net
fluid
loss
antiemet
ineffect
gastroenter
young
children
caus
frequent
dyston
reaction
dehydr
infant
bismuth
subsalicyl
effect
clinic
symptom
probabl
due
antisecretori
effect
soriano
et
al
recommend
routin
larg
concern
potenti
metabol
toxic
concern
trigger
rey
syndrom
cholestyramin
anion
exchang
resin
bind
bile
salt
appear
decreas
clinic
symptom
small
studi
vesikari
isolauri
current
avail
antidiarrh
medic
disappoint
efficaci
viral
enter
young
children
antidiarrh
base
narcot
narcot
analogu
act
mainli
alter
intestin
motil
narcot
tinctur
opium
ale
inappropri
young
children
acut
gastroenter
loperamid
synthet
opioid
rel
free
central
effect
virtual
abus
potenti
loperamid
found
ineffect
treatment
earli
childhood
diarrhea
sever
studi
owen
et
al
kassaem
et
al
vesikari
isolauri
known
caus
life
threaten
ileu
central
nervou
system
intox
children
gastroenter
bhutta
tahir
minton
henri
schwartz
rodriquez
racecadotril
new
class
antidiarrh
medic
inhibit
degrad
endogen
opioidlik
enkephalin
anim
studi
show
racecadotril
much
less
tendenc
caus
small
intestin
bacteri
overgrowth
far
less
cn
toxic
loperamid
duvaliflah
preliminari
studi
children
adult
remark
well
toler
cn
effect
increas
vomit
one
pediatr
ileu
report
date
racecadotril
report
decreas
stool
output
young
children
rotaviru
diarrhea
approxim
durat
diarrhea
hour
hour
salazarlindo
et
al
cezard
thu
far
racecadotril
appear
promis
adjunct
therapi
ort
viral
gastroenter
see
also
lundgren
svensson
section
chapter
book
summari
current
recommend
therapi
viral
gastroenter
children
limit
rehydr
nutrit
support
current
potenti
therapi
summar
tabl
hope
safe
effect
afford
treatment
develop
come
year
